Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
5fU9sB8fKSrfEk1B
Listen
